0000950170-24-076379.txt : 20240621 0000950170-24-076379.hdr.sgml : 20240621 20240621175955 ACCESSION NUMBER: 0000950170-24-076379 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240620 FILED AS OF DATE: 20240621 DATE AS OF CHANGE: 20240621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Polsky Bruce CENTRAL INDEX KEY: 0001508458 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39661 FILM NUMBER: 241061587 MAIL ADDRESS: STREET 1: C/O VISION-SCIENCES, INC. STREET 2: 40 RAMLAND ROAD CITY: ORANGEBURG STATE: NY ZIP: 10962 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001593899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 460574869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 FRANKLIN STREET STREET 2: SUITE 2100 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-204-8109 MAIL ADDRESS: STREET 1: 225 FRANKLIN STREET STREET 2: SUITE 2100 CITY: BOSTON STATE: MA ZIP: 02110 4 1 ownership.xml 4 X0508 4 2024-06-20 0001593899 Atea Pharmaceuticals, Inc. AVIR 0001508458 Polsky Bruce 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 true false false false false Common Stock 2024-06-20 4 S false 17544 3.4852 D 65606 D Restricted Stock Units 2024-06-21 4 A false 29600 0.00 A Common Stock 29600 29600 D Stock Option (Right to Buy) 3.44 2024-06-21 4 A false 41200 0.00 A 2034-06-20 Common Stock 41200 41200 D The shares were sold solely to cover taxes upon the vesting of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.43 to $3.53, inclusive. Restricted stock units convert into common stock on a one-for-one basis. The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. /s/ Andrea Corcoran, as Attorney-in-Fact for Bruce Polsky 2024-06-21